CB Insights - Amazon is risk-on

Hi there, 
 

Here are Amazon's 10 largest M&A deals ever, according to the CB Insights platform:

1) Whole Foods: $13.7B (2017)

2) MGM: $8.5B (2021)

3) One Medical: $3.9B (2022)

4) iRobot: $1.7B (2022)

5) Zoox: $1.3B (2020)

6) Zappos: $1.2B (2009)

7) PillPack: $1B (2018)

7) Ring: $1B (2018)

9) Twitch: $970M (2014)

10) Kiva: $775M (2012)

Two of these happened this year. While most others are risk-off in this environment, Amazon is still risk-on.

Which of these acquisitions goes down as its best M&A deal?

I'd vote for Twitch or Kiva.

Now, Amazon may be eyeing its next big acquisition in healthcare. 

Reports suggest it’s among the bidders for home health services provider Signify Health — another indication that healthcare is high on Amazon’s priority list. We previously mapped out the company’s healthcare strategy here.

For more, check out our report on the industries where Amazon’s disruptive ambitions are clearest.

The blockchain bandwagon

Did you know that insurance has been around for centuries? 

Yes, that’s right. A thousand years ago, sailors were already pooling funds to cover damage to individual ships. 

But the industry has been slow to adopt new tech to enhance the customer experience. With the advancement of blockchain, the tide might finally be turning. 

Insurers are now using blockchain to secure patient information sharing, speed up claims processing, and more. 

Dive deeper into the many ways blockchain is shaking up insurance in this free report.

Bioph-loundering

Biopharma tech is having a difficult year so far. 

In Q2’22 the space saw:

• Funding drop 54% quarter-over-quarter.

• Zero IPOs.

• Its unicorn herd shrink. 

At this rate, by the end of the year, startups in the space will have raised slightly over half of 2021’s full-year total. In the words of Yogi Berra, however, "It ain't over till it's over."

While we wait to see how the rest of the year unfolds, check out the latest on biopharma funding trends in our newly published State of Biopharma Tech Q2’22 report. 

A full plate

Unilever generated more than $52B in sales in 2021, and its products are used by almost half of the world’s population every day.

The CPG giant is looking to get even bigger in the years to come. It has its eyes set on growth centered around sustainability and digital transformation. 

How do we know?

We analyzed Unilever’s investments, partnerships, and acquisitions to uncover its strategic priorities. Clients can dig into its specific focus areas in this strategy map. 

The kids are alright

Early-stage startups are driving medical device innovation.

They are tapping into technologies like artificial intelligence and sensors in order to speed up diagnosis as well as enhance the care experience for patients. 

For example, some companies are working to make glucose monitoring less invasive. 

We look at early-stage activity across a number of areas, from remote patient monitoring to surgical intelligence, to map out how the medical device market is being transformed.

The stage is yours

Here are 4 fintech companies that recently completed a CBI Analyst Briefing. 

• Flutterwave, which is building payments infrastructure focused on Africa, counts PayPal among its partners. [Connect here.]
• Alternative investment platform YieldStreet is featured on our wealth tech market map. [Connect here.]
• India-based Perfios aggregates and analyzes data from financial documents for clients like HDFC Bank and ZestMoney. [Connect here.]
• Retirable aims to help older adults plan for retirement. [Connect here.]

CB Insights clients can click “Connect here” above if they want to speak directly to these companies. Or hit the Connect button in platform to get in touch with any company with a CB Insights profile.
 

Want to get your startup in front of customers, investors, acquirers, and 880,000+ newsletter subscribers? Request a 100% free Analyst Briefing here.

Bloomberg. Enrique Roces (@enrique_roces) covers record carbon tech investment and cites CB Insights data. 

TechCrunch. Natasha Mascarenhas (@nmasc_) dives into Stripe’s TaxJar layoffs and mentions CB Insights research.

Reuters. Anshuman Daga (@anshumandaga), Kane Wu (@GeniusWu), and Yantoultra Ngui (@yantoultrangui) discuss the future of CVC Capital Partners’ stake in GarudaFood and use CB Insights data.
 

P.S. Calling all digital health cos: apply for our Digital Health 150 awards by September 9.